This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Immune dysfuction

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Primary biliary cirrhosis (PBC) is considered as an autoimmune disease.

  • it has a sex distribution similar to other autoimmune diseases
  • most PBC patients have other autoimmune diseases
  • loss of immune tolerance to self-mitochondrial proteins (1)

Evidence in support of autoimmunity includes:

  • specific serum autoantibodies
  • autoreactive T cells
  • adaptive transfer of cholangitis using CD8+ T cells (in murine models)
  • functional T regulatory defects
  • female predominance
  • autoimmune comorbidity
  • MHC association -however, neither humoral nor cytotoxic destruction of the biliary epithelium has been demonstrated

Evidence against autoimmunity includes:

  • absence of disease after autoantibody transfer (in mice)
  • absence of correlation between titre of antimitochondrial antibodies and disease severity48
  • failure to respond to immunosuppressive agents (based on limited data) (1).

Reference;


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.